Real-world analyses powered by IMX Data's healthcare claims dataset.
HEALTHCArE
GLP-1 Drug Market Analysis
Quarterly claims data reveals the explosive growth of GLP-1 drugs — who's prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.
Quarterly claims data reveals the explosive growth of ADC drugs — who's prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.
In-depth analyses and white papers from the IMX Data research team.
Research
Leveraging Alternative Healthcare Data Sources for Investment Analysis
06.19.25
In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.